Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$14.95
+2.65%
Mkt Cap $1.92B
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$12.60
Range $6.00 – $16.00
Implied Upside
-15.7%
Consensus $12.60 vs current $14.95
NASDAQ·Healthcare·Biotechnology
$14.95
+2.65%
Mkt Cap $1.92B
No recent rating data.
Price Target (9 analysts)
$12.60
Range $6.00 – $16.00
-15.7%
Consensus $12.60 vs current $14.95